
Longxing Chemical Stock Co., Ltd.
SZSE:002442.SZ
5.19 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 4,355.429 | 4,272.158 | 4,560.115 | 3,438.539 | 2,295.746 | 2,805.93 | 3,085.737 | 2,702.248 | 1,843.298 | 1,737.069 | 2,438.322 | 2,344.427 | 1,940.447 | 2,043.292 | 1,333.594 | 967.993 | 895.063 | 626.939 |
Cost of Revenue
| 3,889.042 | 3,862.71 | 4,162.828 | 2,931.682 | 1,968.998 | 2,463.213 | 2,574.53 | 2,203.149 | 1,467.352 | 1,487.302 | 2,121.22 | 2,002.768 | 1,627.948 | 1,652.484 | 1,079.518 | 739.361 | 691.315 | 460.774 |
Gross Profit
| 466.387 | 409.448 | 397.287 | 506.857 | 326.748 | 342.717 | 511.207 | 499.099 | 375.946 | 249.767 | 317.101 | 341.659 | 312.499 | 390.807 | 254.076 | 228.632 | 203.748 | 166.165 |
Gross Profit Ratio
| 0.107 | 0.096 | 0.087 | 0.147 | 0.142 | 0.122 | 0.166 | 0.185 | 0.204 | 0.144 | 0.13 | 0.146 | 0.161 | 0.191 | 0.191 | 0.236 | 0.228 | 0.265 |
Reseach & Development Expenses
| 38.608 | 28.059 | 27.68 | 25.207 | 13.961 | 15.938 | 18.407 | 17.39 | 14.415 | 16.455 | 17.16 | 15.237 | 15.595 | 18.613 | 1.134 | 0 | 0 | 0 |
General & Administrative Expenses
| 73.724 | 63.297 | 58.27 | 53.248 | 30.863 | 33.488 | 42.781 | 37.036 | 44.223 | 34.115 | 34.238 | 30.075 | 28.766 | 14.076 | 18.528 | 31.086 | 36.572 | 24.797 |
Selling & Marketing Expenses
| 16.457 | 18.625 | 27.704 | 29.655 | 21.434 | 113.242 | 121.698 | 138.517 | 145.925 | 112.272 | 123.515 | 121.93 | 114.562 | 115.639 | 84.519 | 65.215 | 64.948 | 38.775 |
SG&A
| 90.181 | 81.922 | 85.974 | 82.903 | 52.297 | 146.73 | 164.479 | 175.552 | 190.148 | 146.387 | 157.753 | 152.005 | 143.327 | 129.715 | 103.047 | 96.301 | 101.52 | 63.571 |
Other Expenses
| 174.345 | 0 | 119.912 | 115.514 | 92.559 | 98.589 | 112.841 | 105.256 | 21.765 | 9.548 | 15.583 | 24.864 | 18.041 | 20.423 | 9.472 | 2.944 | 1.52 | 31.716 |
Operating Expenses
| 303.135 | 274.786 | 233.566 | 223.625 | 158.816 | 261.258 | 295.726 | 298.198 | 291.015 | 250.7 | 250.375 | 242.614 | 213.955 | 196.395 | 136.884 | 103.399 | 105.055 | 65.852 |
Operating Income
| 163.252 | 175.114 | 170.895 | 288.152 | 193.248 | 123.912 | 159.074 | 192.555 | 31.846 | -103.78 | -6.534 | 0.128 | 28.971 | 127.126 | 75.696 | 87.611 | 39.211 | 85.823 |
Operating Income Ratio
| 0.037 | 0.041 | 0.037 | 0.084 | 0.084 | 0.044 | 0.052 | 0.071 | 0.017 | -0.06 | -0.003 | 0 | 0.015 | 0.062 | 0.057 | 0.091 | 0.044 | 0.137 |
Total Other Income Expenses Net
| -2.049 | -48.822 | -30.238 | -64.439 | -72.223 | -39.203 | -40.758 | -71.194 | -35.703 | -63.093 | -76.827 | -72.883 | -49.431 | -32.863 | -21.88 | -28.016 | -33.95 | 16.5 |
Income Before Tax
| 161.203 | 126.292 | 113.985 | 195.075 | 97.313 | 22.955 | 154.107 | 74.145 | 45.239 | -97.113 | 8.704 | 23.771 | 46.166 | 147.549 | 84.951 | 90.527 | 39.344 | 117.54 |
Income Before Tax Ratio
| 0.037 | 0.03 | 0.025 | 0.057 | 0.042 | 0.008 | 0.05 | 0.027 | 0.025 | -0.056 | 0.004 | 0.01 | 0.024 | 0.072 | 0.064 | 0.094 | 0.044 | 0.187 |
Income Tax Expense
| 19.117 | 15.89 | 10.294 | 23.441 | 19.858 | 3.734 | 21.386 | 24.527 | 14.432 | -14.681 | -6.299 | 4.889 | 5.54 | 23.787 | 12.442 | 21.261 | 8.686 | 13.676 |
Net Income
| 142.087 | 110.402 | 103.691 | 171.634 | 77.456 | 19.221 | 132.721 | 49.959 | 30.819 | -82.432 | 15.003 | 19.51 | 44.047 | 122.23 | 72.51 | 69.266 | 30.658 | 103.864 |
Net Income Ratio
| 0.033 | 0.026 | 0.023 | 0.05 | 0.034 | 0.007 | 0.043 | 0.018 | 0.017 | -0.047 | 0.006 | 0.008 | 0.023 | 0.06 | 0.054 | 0.072 | 0.034 | 0.166 |
EPS
| 0.29 | 0.23 | 0.22 | 0.36 | 0.16 | 0.04 | 0.28 | 0.1 | 0.064 | -0.17 | 0.031 | 0.041 | 0.09 | 0.25 | 0.17 | 0.19 | 0.083 | 0.29 |
EPS Diluted
| 0.29 | 0.23 | 0.22 | 0.36 | 0.16 | 0.04 | 0.28 | 0.1 | 0.064 | -0.17 | 0.031 | 0.041 | 0.09 | 0.25 | 0.17 | 0.19 | 0.083 | 0.29 |
EBITDA
| 312.005 | 275.408 | 258.343 | 360.453 | 261.327 | 186.94 | 328.576 | 256.171 | 216.035 | 109.2 | 215.534 | 216.355 | 201.773 | 259.7 | 157.465 | 157.547 | 104.485 | 135.834 |
EBITDA Ratio
| 0.072 | 0.064 | 0.057 | 0.105 | 0.114 | 0.067 | 0.106 | 0.095 | 0.117 | 0.063 | 0.088 | 0.092 | 0.104 | 0.127 | 0.118 | 0.163 | 0.117 | 0.217 |